Joe Muldoon is the Chief Executive Officer for FAST BioMedical, a privately held, clinical stage medical company currently developing technology for quantifying plasma volume and kidney function. He leverages 27 years of experience, from technology start-ups to publicly traded multi-national companies. He has worked with many high-growth entrepreneurial companies as a Board advisor, investor, and CEO. He previously served as an Entrepreneur in Residence of the Indiana Venture Center and President of Brightpoint North America (NASDAQ:CELL) Mr. Muldoon has a Bachelor of Science in Business from Indiana University’s Kelley School of Business, where he is a frequent panelist and speaker for MBA programs.
He serves on the Boards of Confluence Pharmaceuticals, Heart Reach Carmel and FAST BioMedical. He has previously served on the Boards of TGX Medical, Jameson, Inc., Venture Club of Indiana, and InfoDynamics.
KHI Member support provided by: FAST BioMedical